Affiliation:
1. All India Institute of Medical Sciences, Kalyani, West Bengal, India
Abstract
The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC), first published in 2018, attempted to develop a standardized and objective system of reporting salivary gland fine needle aspiration smears. It was widely accepted by the cytopathologists who started using it in their day-to-day practice. With the publication of new literature, the Milan system was updated and the 2 edition was released in 2023. The 5 WHO classification of salivary neoplasms, ancillary tests, and imaging characteristics of various salivary neoplasms have also been highlighted in the new edition. The 3 indeterminate categories of the Milan system of reporting are the atypia of undetermined significance (AUS), salivary gland tumor of undetermined malignant potential (SUMP), and suspicious for malignancy (SM) that create major dilemmas for the reporting cytopathologists. The present minireview highlights the criteria of diagnosis and further workup of the various lesions in these categories.
Publisher
IP Innovative Publication Pvt Ltd
Reference30 articles.
1. WC Faquin, ED Rossi, .The Milan System for Reporting Salivary Gland Cytopathology.1-13
2. Jalaly JB, Farahani SJ, Baloch ZW, The Milan System for reporting salivary gland cytopathology: a comprehensive review of the literature.Diagn Cytopathol 2020;48(10):880-9
3. Song SJ, Shafique K, Wong LQ, Livolsi VA, Montone KT, Baloch Z, The utility of the Milan system as a risk stratification tool for salivary gland fine needle aspiration cytology specimens.Cytopathology 2019;30(1):91-8
4. WC Faquin, ED Rossi, Atypia of Undetermined Significance” (AUS).The Milan System for Reporting Salivary Gland Cytopathology.49-70
5. WC Faquin, ED Rossi, Ancillary Studies for Salivary Gland Cytology.The Milan System for Reporting Salivary Gland Cytopathology.165-9